Showing results (601-610 of 1,340) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|February 19, 2026
Age is not enough: Clinical and therapeutic predictors of survival in elderly patients with de novo glioblastomaRaquel Gutiérrez-González, Zulema Herrero, Ana Royuela, et al.
Neuro-Oncology Advances|February 23, 2026
From the gut to the brain: The involvement of the gut microbiota in the development and progression of glioblastomaDaniela Toumazi, Christiana Charalambous, Constantina Constantinou, et al.
Neuro-Oncology Advances|March 2, 2026
Single-cell multi-omic techniques highlight the diverse composition and intercellular interactions of the vestibular schwannoma tumor microenvironmentShree S Pari, Sangami Pugazenthi, Albert H Kim, et al.
Neuro-Oncology Advances|March 2, 2026
A phase 2 study of abemaciclib in patients with brain metastases secondary to non-small cell lung cancer or melanomaSolmaz Sahebjam, Danielle A Bazer, Emilie Le Rhun, et al.
Neuro-Oncology Advances|February 27, 2026
Epigenetic maintenance of the injury response state in glioblastoma stem cellsFatemeh Molaei, Graham MacLeod, Shahan Haider, et al.
Neuro-Oncology Advances|April 1, 2026
Marginal diffusion slope as a prognostic imaging biomarker of infiltrating phenotype in glioblastoma; A cancer imaging biomarker roadmap studyAntoine Vallatos, Haitham F I Al-Mubarak, Joanna L Birch, et al.
Neuro-Oncology Advances|March 30, 2026
Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, IDH-wildtypeDaniel H Lachance, Paul A Decker, Thomas M Kollmeyer, et al.
Neuro-Oncology Advances|February 27, 2026
Proteomics in IDH-mutated diffuse lower-grade glioma: a scoping reviewCarl-Johan Kihlstedt, Anna Dénes, Alireza Mansouri, et al.
Neuro-Oncology Advances|March 24, 2026
Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohortDavid Rieger, Hannes Becker, Bianca Walter, et al.
Neuro-Oncology Advances|March 30, 2026
Adoptive cellular therapy prevents reconstitution of myeloid-derived suppressor cells in the glioma tumor microenvironmentJohn W Figg, Caitland Love, Sofia Stansbury, et al.
Pageof 134